LifeCycle Pharma Receives US Patent for its MeltDose Technology

18-May-2007

LifeCycle Pharma A/S announced the issuance of a patent for its MeltDose® Technology by the US Patent and Trademark Office, US Patent No. 7,217,431. The patent covers the method of making a particulate material containing a drug substance with low aqueous solubility, using a unique controlled agglomeration process. The issue of the MeltDose® patent does not change the company's financial expectations for 2007.

Other news from the department research and development

Most read news

More news from our other portals

Fighting cancer: latest developments and advances